TAC regimen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:TAC; TAC Regimen; TAC regimen; Taxotere-Adriamycin-Cytoxan Regimen
Overview
TAC regimen refers to a regimen consisting of docetaxel (taxotere), doxorubicin and cyclophosphamide used in the adjuvant setting for the treatment of breast cancer.[1][2]
Regimen
TDocetaxel (Taxotere)
ADoxorubicin (Adriamycin)
CCyclophosphamide
Indications
References
- ↑ 1.0 1.1 Martin M (2006). “Docetaxel, doxorubicin and cyclophosphamide (the TAC regimen): an effective adjuvant treatment for operable breast cancer”. Womens Health (Lond Engl). 2 (4): 527–37. doi:10.2217/17455057.2.4.527. PMID 19803960.
- ↑ “NCI Thesaurus”.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
